Motilin receptor
Motilin receptor is a G protein-coupled receptor that binds motilin, a 22-amino acid peptide hormone primarily involved in the regulation of gastrointestinal motility. The motilin receptor plays a crucial role in mediating the actions of motilin, particularly in stimulating gastric emptying and intestinal motility. This receptor is predominantly expressed in the gastrointestinal tract, especially in the stomach and duodenum, where it facilitates the coordination of digestive processes.
Function[edit | edit source]
The primary function of the motilin receptor is to mediate the effects of motilin, which include the stimulation of gastric motility and the initiation of the migrating motor complex (MMC). The MMC is a cyclic, recurring motility pattern that occurs in the stomach and small intestine during fasting. Activation of the motilin receptor by motilin leads to increased peristalsis, facilitating the movement of food and digestive enzymes through the gastrointestinal tract. This process is essential for the efficient digestion and absorption of nutrients.
Structure[edit | edit source]
As a member of the G protein-coupled receptor family, the motilin receptor possesses the characteristic seven transmembrane domains. These receptors are known for their ability to transduce extracellular signals through the activation of G proteins, leading to various intracellular responses. The specific structure of the motilin receptor allows it to bind motilin with high affinity, initiating a cascade of signaling events that promote gastrointestinal motility.
Clinical Significance[edit | edit source]
The motilin receptor is a target for the development of drugs aimed at treating gastrointestinal disorders, such as gastroparesis and functional dyspepsia. Agonists of the motilin receptor can enhance gastric emptying and may be beneficial in conditions characterized by delayed gastric emptying. Conversely, antagonists may find use in conditions where reduced gastrointestinal motility is desired.
Pharmacology[edit | edit source]
Several pharmacological agents have been developed to target the motilin receptor, including both agonists and antagonists. Agonists mimic the action of motilin, promoting gastrointestinal motility, while antagonists block the receptor, reducing motility. The therapeutic potential of these agents lies in their ability to modulate gastrointestinal motility, offering a strategy for managing various motility disorders.
Research Directions[edit | edit source]
Research on the motilin receptor continues to explore its role in gastrointestinal physiology and its potential as a therapeutic target. Studies are investigating the receptor's involvement in other physiological processes and its interaction with other hormones and neurotransmitters. Understanding the complex signaling pathways and regulatory mechanisms of the motilin receptor may lead to new therapeutic approaches for gastrointestinal diseases.
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD